CILO INNOVATIONS LTD

Company number 12823552 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

CILO INNOVATIONS LTD - Analysis Report

Company Number: 12823552

Analysis Date: 2025-07-20 14:48 UTC

Financial Health Assessment for CILO INNOVATIONS LTD


1. Financial Health Score: C+

Explanation:
The company exhibits some positive signs such as no current liabilities and modest net current assets, indicating a symptom of financial stability. However, the absence of turnover and decreasing net assets over recent years signal challenges in generating operational cash flow and growth. Overall, the company’s financial health is cautiously stable but requires attention to generate sustainable revenue streams.


2. Key Vital Signs

Metric Latest Value (2024) Interpretation
Turnover £0 No revenue generation; key "vital sign" is absent.
Fixed Assets £0 No investment in long-term assets; low capital base.
Current Assets £7,065 Modest liquid resources; represents "healthy cash flow" reserve.
Current Liabilities £0 No short-term debts; good liquidity without pressure.
Net Current Assets £7,065 Positive working capital; no immediate cash flow distress.
Net Assets / Shareholders Funds £7,065 Equity base has shrunk from £21,065 in 2023, indicating potential asset depletion or loss absorption.
Employee Count 1 Very small operation; minimal personnel cost but limited scale.
Share Capital £16 Minimal equity injection; company likely relies on other financing or retained funds.

3. Diagnosis: What the Financial Data Reveals About Business Health

  • Symptom of Revenue Absence: The company has reported zero turnover for at least the last three fiscal years. This is a critical symptom indicating the business is not generating operating income, which could reflect early-stage development, market challenges, or product/service issues.

  • Stable but Limited Liquidity: With current assets exceeding current liabilities and no short-term debts, the company holds a "healthy cash flow" cushion. However, the cash or liquid assets have decreased from £21,065 in 2023 to £7,065 in 2024, suggesting cash burn without replenishment.

  • Minimal Capital Base: Fixed assets stand at zero, implying no investment in property, plant, or equipment. This is not unusual for a software publishing company but limits collateral and borrowing capacity.

  • Shrinking Equity: Shareholders’ funds dropped by about £14,000 year-over-year, indicating operating losses or distributions exceeding income. This signals "symptoms of distress" if the trend continues.

  • Small Scale Operation: With only one employee, the company operates at a micro level. This minimizes overhead but also restricts capacity for growth or diversification.

  • Governance and Control: The company is controlled by two directors with significant ownership stakes, allowing for clear decision-making but potential concentration risk.


4. Recommendations: Specific Actions to Improve Financial Wellness

  • Develop Revenue Streams: The foremost priority is to initiate or ramp up trading activities to generate turnover. Without sales, the company’s financial health cannot improve sustainably.

  • Cost Control and Cash Flow Management: Monitor cash reserves closely to avoid liquidity crises. Consider seeking additional funding or investment if cash depletion continues.

  • Explore Strategic Partnerships: Collaboration with other technology or software firms may provide access to markets, customers, and resources.

  • Consider Asset Investments: Evaluate if investing in specific fixed assets or intellectual property could enhance operational capability or competitive advantage.

  • Regular Financial Monitoring: Establish monthly financial reviews to detect early signs of distress and adjust plans accordingly.

  • Review Business Model and Market Fit: Conduct a strategic review to understand barriers to revenue generation and adapt product offerings or marketing strategies.


Medical Analogy Summary:

CILO INNOVATIONS LTD currently shows a "stable pulse" with positive net current assets and no short-term liabilities, indicating no immediate financial distress. However, the "absence of revenue heartbeat" is a significant concern, reflecting a dormant or early-stage business struggling to generate income. The "shrinking equity body mass" points to resource depletion, requiring urgent remedial actions to restore vitality and growth potential.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.